Wednesday, November 12, 2008

Kenneth Londoner appointed to Aduromed board

By Mass High Tech Staff

Medical waste treatment systems manufacturer Aduromed Industries Inc. has announced that Kenneth L. Londoner has been elected to the Aduromed board of directors.

Londoner leads business development and corporate finance for cardiac diagnostics firm NewCardio Inc., where he raised $14.6 million in public financing and navigated the process of making the company a public entity.

Prior to his role at NewCardio, Londoner led the $7 million startup financing of Safe Ports LLC, a port security services firm he co-founded. At Safe Ports, and its wholly-owned subsidiary Carolina Linkages Inc., he served as executive vice president. Earlier than that, Londoner served as founder, CEO and general partner of hedge fund management firm Red Coat Capital Management.

In September, Aduromed (OTC: ADRM) announced that Scott Grisanti had been appointed chief executive officer of the company, replacing founder and acting CEO at the time, Damien Tanaka. Tanaka now handles new products as chief development officer.

Aduromed develops the MedClean Series system that treats bio-hazardous regulated medical waste and converts it into sterile disposable material. The company, founded in 1997, is a wholly-owned subsidiary of Aduromed Corp. and operates its headquarters, research and development and distribution facilities in Bethel, Conn.